Analysis of Biomarkers and Marginal Bone Loss in Platform-Switched and Nonplatform-Switched Implants: A Randomized Clinical Trial

Table 4

Biomarker levels in PICF for both groups.

	PS	NPS	(†)
	RANKL at	ng/ml		1 ng/ml	0.422
RANKL at	ng/ml	ng/ml	0.532
OPG at	ng/ml	ng/ml	0.025
OPG at	ng/ml	ng/ml	0.236
RANKL/OPG at			0.038
RANKL/OPG at			0.197
MCP-1 at	pg/ml	pg/ml	0.740
MCP-1 at	pg/ml	pg/ml	0.006
IL-1β at	pg/ml	pg/ml	0.116
IL-1β at	pg/ml	pg/ml	0.019

Comparison of the values between the groups was performed using Student’s -test †, .